Skip to main navigation Skip to search Skip to main content

Treatment for Immune Thrombocytopenia in Coronavirus Disease 2019 (COVID-19) Infection after COVID-19 Vaccination: A Case Report

  • Jun Hee Lee
  • , Sang Min Oh
  • , Eunyoung Lee*
  • , Ji Hwan Bang
  • , Sang Won Park
  • *Corresponding author for this work
  • Seoul National University
  • SMG-SNU Seoul Boramae Medical Center

Research output: Contribution to journalJournal articlepeer-review

Abstract

Thrombocytopenia is one of the rare signs of both the coronavirus disease 2019 (COVID-19) and COVID-19 vaccination. An 85-year-old man was diagnosed with immune thrombocytopenia and COVID-19, 7 days after COVID-19 vaccination. The patient was successfully treated with a short course of intravenous immunoglobulin and oral corticosteroids.

Original languageEnglish
Article numbere72
JournalInfection and Chemotherapy
Volume53
DOIs
StatePublished - 2021.12

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Coronavirus disease 2019
  • Covid-19 vaccines
  • SARS-CoV-2
  • Vaccine-induced immune thrombocytopenia

Fingerprint

Dive into the research topics of 'Treatment for Immune Thrombocytopenia in Coronavirus Disease 2019 (COVID-19) Infection after COVID-19 Vaccination: A Case Report'. Together they form a unique fingerprint.

Cite this